...se results, pyridoxamine has been investigated for clinical utility in the treatment of [[diabetic nephropathy]].
...ary supplement, the company would be unable to charge enough money for the treatment (should it be approved as a prescription drug by the FDA) for the investors
...
9 KB (1,212 words) - 14:40, 4 April 2024
...se results, pyridoxamine has been investigated for clinical utility in the treatment of [[diabetic nephropathy]].
...ary supplement, the company would be unable to charge enough money for the treatment (should it be approved as a prescription drug by the FDA) for the investors
...
9 KB (1,244 words) - 14:38, 4 April 2024
...ation|FDA]]), as an [[Investigational New Drug]] (IND) application. If the IND is approved, development moves to the clinical phase.
...finding studies and comparisons against both a placebo and a gold-standard treatment arm play a major role in achieving reliable data.<ref name="portfolio2012">
...
26 KB (3,425 words) - 08:08, 4 January 2023
...erse pharmacology/ja|リバース・ファーマコロジー]]（逆薬理学）として知られるプロセスで、[[Disease-modifying treatment/ja|疾患修飾作用]]があると仮定される単離された[[biological target/ja|生物学的標的]]に対して、大量の化合物ライブラリーを[
米国内では、承認前の需要は、一般的に[[treatment IND/ja|治療IND]]（治験薬）申請（IND）、または単一患者INDによって満たされる。これらの制度は、拡大アクセス・プログラムに分類され、米国内に居住する患者グループまたは個人に対して薬物へのア
...
58 KB (1,845 words) - 17:09, 5 November 2023
...bstance intended for use in the [[diagnosis|diagnosis]], cure, mitigation, treatment, or [[prevention of disease|prevention of disease]].
...rget|biological target]]s which are hypothesized to be [[Disease-modifying treatment|disease-modifying]] in a process known as [[reverse pharmacology|reverse ph
...
52 KB (6,923 words) - 17:09, 5 November 2023
...bstance intended for use in the [[diagnosis|diagnosis]], cure, mitigation, treatment, or [[prevention of disease|prevention of disease]].
...rget|biological target]]s which are hypothesized to be [[Disease-modifying treatment|disease-modifying]] in a process known as [[reverse pharmacology|reverse ph
...
54 KB (7,245 words) - 17:08, 5 November 2023
..., pharmaceutical companies move forward with the Investigational New Drug (IND) Application from the [[Food and Drug Administration|FDA]].<ref name=":2" /
...Net Prices.png|thumb|Research and development investments vs log-adjusted treatment costs at launch based on list prices and net prices<ref name="10.1001/jaman
...
43 KB (5,918 words) - 08:11, 4 January 2023
...]). By 1929 epinephrine had been formulated into an inhaler for use in the treatment of nasal congestion.
...zedrine|Benzedrine Inhaler.]] Amphetamine was eventually developed for the treatment of [[narcolepsy]], [[post-encephalitic parkinsonism]], and mood elevation i
...
60 KB (8,551 words) - 22:13, 8 January 2023
...sed in the traditional Austrian medicine internally as tea or tincture for treatment of disorders of the gastrointestinal tract, respiratory tract, nervous syst
}}</ref> and, in [[traditional Chinese medicine]] as a treatment for sore throat and symptoms of the common cold.<ref>{{cite web
...
114 KB (14,880 words) - 23:34, 3 January 2023